4//SEC Filing
BIOGEN IDEC INC. 4
Accession 0001127602-15-005309
$BIIBCIK 0000875045operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:08 PM ET
Size
14.2 KB
Accession
0001127602-15-005309
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Kingsley Stuart A
EVP, Global Comm. Operations
Transactions
- Exercise/Conversion
Common Stock
2015-02-08+2,636→ 6,147 total - Tax Payment
Common Stock
2015-02-08$402.00/sh−883$354,966→ 5,264 total - Exercise/Conversion
Common Stock
2015-02-09+1,824→ 7,088 total - Tax Payment
Common Stock
2015-02-09$396.88/sh−860$341,317→ 6,228 total - Exercise/Conversion
Restricted Stock Unit
2015-02-08−2,636→ 2,639 totalExercise: $0.00Exp: 2016-02-08→ Common Stock (2,636 underlying) - Exercise/Conversion
Restricted Stock Unit
2015-02-09−1,824→ 0 totalExercise: $0.00Exp: 2015-02-09→ Common Stock (1,824 underlying)
Footnotes (2)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- [F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:08 PM ET
- Size
- 14.2 KB